Dupilimab
Alternative Names: Dupixent
Dupilumab, marketed under the brand name Dupixent, is a biologic medication used for the treatment of moderate to severe atopic dermatitis (eczema) in adults and children. It is also used to manage other conditions such as asthma and chronic rhinosinusitis with nasal polyps. Dupilumab is particularly effective for individuals whose eczema is not adequately controlled with topical treatments or when systemic therapy is warranted.
Treatment Type: Prescription Medication
Treatment Class: IL-4 antagonist
Treatment Modality: Injection
Review Summary
Based on the limited information provided, with only one review and a rating of 3 out of 5, it is difficult to comprehensively assess the effectiveness of Dupilimab against Eczema. More reviews and ratings would be necessary to draw a reliable conclusion about the treatment's efficacy.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
4.0
AI Summary of User Experiences
Not medical advice.
Based on the limited information provided, with only one review and a rating of 3 out of 5, it is difficult to comprehensively assess the effectiveness of Dupilimab against Eczema. More reviews and ratings would be necessary to draw a reliable conclusion about the treatment's efficacy.
Reviews
Filter by reviewer type Pro